MIR3178

Across TCGA pan-cancer cohorts, MIR3178 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated MIR3178 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3178 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR3178 expression acts as an unfavorable survival marker, although some lineages such as MESO and BRCA show a favorable association.

MESO, BRCA, and ACC are the cancer types where MIR3178 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Median	III,IV	0.473	0.279	.006	51	view →
BRCA	DFS	Tertile	III,IV	0.660	0.405	.001	41	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	39	view →
OV	OS	Quartile	All	0.267	0.409	.007	32	view →
DLBC	OS	Tertile	All	0.777	0.963	.026	26	view →
KIRP	OS	Quartile	All	0.981	0.892	.005	22	view →
LUAD	OS	Median	All	0.734	0.634	.006	19	view →
PAAD	OS	Median	II,III,IV	0.722	0.349	.014	13	view →
THYM	DFS	Median	III,IV	1.000	0.471	.014	12	view →
PCPG	OS	Tertile	All	0.939	1.000	.034	9	view →
LIHC	DFS	Tertile	III,IV	0.587	0.246	.024	8	view →
THCA	DFS	Quartile	II,III,IV	0.583	0.847	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

MIR3178–MESO (DFS)

Open the MESO breakdown →